BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 23093495)

  • 1. Requirement of apoptotic protease-activating factor-1 for bortezomib-induced apoptosis but not for Fas-mediated apoptosis in human leukemic cells.
    Ottosson-Wadlund A; Ceder R; Preta G; Pokrovskaja K; Grafström RC; Heyman M; Söderhäll S; Grandér D; Hedenfalk I; Robertson JD; Fadeel B
    Mol Pharmacol; 2013 Jan; 83(1):245-55. PubMed ID: 23093495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JNK and AP-1 mediate apoptosis induced by bortezomib in HepG2 cells via FasL/caspase-8 and mitochondria-dependent pathways.
    Lauricella M; Emanuele S; D'Anneo A; Calvaruso G; Vassallo B; Carlisi D; Portanova P; Vento R; Tesoriere G
    Apoptosis; 2006 Apr; 11(4):607-25. PubMed ID: 16528474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptogenic activity of 2α,3α-dihydroxyurs-12-ene-28-oic acid from Prunella vulgaris var. lilacina is mediated via mitochondria-dependent activation of caspase cascade regulated by Bcl-2 in human acute leukemia Jurkat T cells.
    Woo HJ; Jun do Y; Lee JY; Woo MH; Yang CH; Kim YH
    J Ethnopharmacol; 2011 Jun; 135(3):626-35. PubMed ID: 21473903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic induction of oxidative injury and apoptosis in human multiple myeloma cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitors.
    Pei XY; Dai Y; Grant S
    Clin Cancer Res; 2004 Jun; 10(11):3839-52. PubMed ID: 15173093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pivotal role for Mcl-1 in Bortezomib-induced apoptosis.
    Podar K; Gouill SL; Zhang J; Opferman JT; Zorn E; Tai YT; Hideshima T; Amiot M; Chauhan D; Harousseau JL; Anderson KC
    Oncogene; 2008 Jan; 27(6):721-31. PubMed ID: 17653083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions.
    Reis-Sobreiro M; Gajate C; Mollinedo F
    Oncogene; 2009 Sep; 28(36):3221-34. PubMed ID: 19561642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celecoxib activates a novel mitochondrial apoptosis signaling pathway.
    Jendrossek V; Handrick R; Belka C
    FASEB J; 2003 Aug; 17(11):1547-9. PubMed ID: 12824303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Apoptosis of myeloid leukemia cell line HL60 induced by Bortezomib, a proteasome inhibitor].
    Fu YB; Sun QX; Meng FY; Xie J; Zhou GB
    Zhonghua Yi Xue Za Zhi; 2006 Sep; 86(34):2413-6. PubMed ID: 17156654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BAG3 gene silencing sensitizes leukemic cells to Bortezomib-induced apoptosis.
    Liu P; Xu B; Li J; Lu H
    FEBS Lett; 2009 Jan; 583(2):401-6. PubMed ID: 19111544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of the proteasome inhibitor bortezomib on acute myeloid leukemia cells and drug resistance associated with the CD34+ immature phenotype.
    Colado E; Alvarez-Fernández S; Maiso P; Martín-Sánchez J; Vidriales MB; Garayoa M; Ocio EM; Montero JC; Pandiella A; San Miguel JF
    Haematologica; 2008 Jan; 93(1):57-66. PubMed ID: 18166786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.
    Huerta S; Heinzerling JH; Anguiano-Hernandez YM; Huerta-Yepez S; Lin J; Chen D; Bonavida B; Livingston EH
    J Surg Res; 2007 Sep; 142(1):184-94. PubMed ID: 17603079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the proteasome inhibitor, bortezomib, on apoptosis in isolated lymphocytes obtained from patients with chronic lymphocytic leukemia.
    Pahler JC; Ruiz S; Niemer I; Calvert LR; Andreeff M; Keating M; Faderl S; McConkey DJ
    Clin Cancer Res; 2003 Oct; 9(12):4570-7. PubMed ID: 14555532
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of (15S)-hydroperoxyeicosatetraenoic acid and (15S)-hydroxyeicosatetraenoic acid on the acute- lymphoblastic-leukaemia cell line Jurkat: activation of the Fas-mediated death pathway.
    Kumar KA; Arunasree KM; Roy KR; Reddy NP; Aparna A; Reddy GV; Reddanna P
    Biotechnol Appl Biochem; 2009 Feb; 52(Pt 2):121-33. PubMed ID: 18494609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol induces extensive apoptosis by depolarizing mitochondrial membranes and activating caspase-9 in acute lymphoblastic leukemia cells.
    Dörrie J; Gerauer H; Wachter Y; Zunino SJ
    Cancer Res; 2001 Jun; 61(12):4731-9. PubMed ID: 11406544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noxa up-regulation and Mcl-1 cleavage are associated to apoptosis induction by bortezomib in multiple myeloma.
    Gomez-Bougie P; Wuillème-Toumi S; Ménoret E; Trichet V; Robillard N; Philippe M; Bataille R; Amiot M
    Cancer Res; 2007 Jun; 67(11):5418-24. PubMed ID: 17545623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rituximab modifies the cisplatin-mitochondrial signaling pathway, resulting in apoptosis in cisplatin-resistant non-Hodgkin's lymphoma.
    Alas S; Ng CP; Bonavida B
    Clin Cancer Res; 2002 Mar; 8(3):836-45. PubMed ID: 11895917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IFN-alpha and bortezomib overcome Bcl-2 and Mcl-1 overexpression in melanoma cells by stimulating the extrinsic pathway of apoptosis.
    Lesinski GB; Raig ET; Guenterberg K; Brown L; Go MR; Shah NN; Lewis A; Quimper M; Hade E; Young G; Chaudhury AR; Ladner KJ; Guttridge DC; Bouchard P; Carson WE
    Cancer Res; 2008 Oct; 68(20):8351-60. PubMed ID: 18922907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAHA induces apoptosis in hepatoma cells and synergistically interacts with the proteasome inhibitor Bortezomib.
    Emanuele S; Lauricella M; Carlisi D; Vassallo B; D'Anneo A; Di Fazio P; Vento R; Tesoriere G
    Apoptosis; 2007 Jul; 12(7):1327-38. PubMed ID: 17351739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancer-specific toxicity of apoptin is independent of death receptors but involves the loss of mitochondrial membrane potential and the release of mitochondrial cell-death mediators by a Nur77-dependent pathway.
    Maddika S; Booy EP; Johar D; Gibson SB; Ghavami S; Los M
    J Cell Sci; 2005 Oct; 118(Pt 19):4485-93. PubMed ID: 16179607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome inhibitors trigger NOXA-mediated apoptosis in melanoma and myeloma cells.
    Qin JZ; Ziffra J; Stennett L; Bodner B; Bonish BK; Chaturvedi V; Bennett F; Pollock PM; Trent JM; Hendrix MJ; Rizzo P; Miele L; Nickoloff BJ
    Cancer Res; 2005 Jul; 65(14):6282-93. PubMed ID: 16024630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.